Emi Takamitsu1, Midori Yoshimura1, Mitsuyoshi Ohba1, Hirofumi Yamano1, Masafumi Matsuguma2, Toshiaki Yujiri2 (1.Life Science Technology Group, Toyo Kohan Co., Ltd., Yamaguchi, Japan, 2.3rd Department of Internal Medicine, Yamaguchi University Hospital, Yamaguchi, Japan)
Session information
Poster Session
Sat.Oct,12
Poster Session 2-11 MPN: Basic (2)
Sat. Oct 12, 2019 5:10 PM - 5:45 PM Poster (Tokyo International Forum, B2F Hall E)
Chair: Yuka Sugimoto (Department of Community Hematology, Mie University)
Yoshihiko Kihara1,2, Nami Masubuchi1,3, Lilin Zhang4, Marito Araki5, Norio Komatsu1 (1.Department of Hematology, Juntendo University, Tokyo, Japan, 2.Leading Center for the Development and Research of Cancer Medicine, 3.Research Institute for Disease of Old Age, 4.Perseus Proteomics, Inc., 5.Department of Transfusion Medicine and Stem Cell Regulation)
Sota Kitazawa1, Marito Araki2, Kaho Shioiri1, Soji Morishita2, Nami Masubuchi1,3, Terumi Baba1, Seiji Yamamoto4, Yoshiyuki Horiuchi4, Misa Imai1,5, Akimichi Ohsaka2, Norio Komatsu1 (1.Dept. Hematol., Juntendo Univ., Tokyo, Japan, 2.Dept. Transfus. Med. and Stem Cell Reg., Juntendo Univ., Japan, 3.Research Institute for Disease of Old Age., Juntendo Univ., Japan, 4.Research & Development Center, Fuso Pharmaceutical Industries., LTD., Osaka, Japan, 5.Lead. Cent. Dev. Res. Center Med., Juntendo Univ., Tokyo, Japan)
Hiroyuki Ebinuma1, Ikumi Suzuki1, Masahiro Takeuchi2, Emiko Sakaida2 (1.SEKISUI MEDICAL CO.,LTD Tsukuba Research Institute, Ibaraki, Japan, 2.Department of Hematology, Chiba University Hospital, Chiba, Japan)
Akihiko Arai1, Makoto Yoshimitsu1, Maki Otsuka2, Yoshikiyo Ito3, Nobuaki Nakano3, Kosuke Obama4, Takayoshi Miyazono3, Masahito Tokunaga3, Jun Odawara3, Ayumu Kubota3, Tomohisa Tabuchi3, Maiko Hayashida1, Yuhei Kamada1, Daisuke Nakamura1, Heiichiro Hamada1, Satoshi Fujino2, Hirosaka Inoue4, Koichi Haraguchi2, Satsuki Owatari2, Shuichi Hanada2, Miho Hachiman1, Yuichiro Uchida1, Kenji Ishitsuka1 (1.Department of Hematology and Immunology, Kagoshima University Hospital, Kagoshima, Japan, 2.Department of Hematology, National Hospital Organization Kagoshima Medical Center, Japan, 3.Department of Hematology, Imamura General Hospital, Kagoshima, Japan, 4.Department of Hematology, Imakiire General Hospital, Kagoshima, Japan)
Ryujiro Hara1, Chisa Okada2, Rikio Suzuki1, Shinichiro Machida1, Ken Ohmachi1, Makoto Onizuka1, Yukari Shirasugi1, Yoshiaki Ogawa1, Hiroshi Kawada1, Kiyoshi Ando1 (1.Division of Hematology/Oncology, Tokai University School of Medicine, Kanagawa, Japan, 2.Support Center, Tokai University School of Medicine, Kanagawa, Japan)
Yuichi Ikeda, Jun Yamanouchi, Takaaki Hato, Katsuto Takenaka (Hematol., Ehime Univ., Ehime, Japan)